发明名称 |
COMBINACION DE AL MENOS DOS AGENTES ANTIVIRALES DE ACCION DIRECTA, RIBAVIRINA PERO NO INTERFERON PARA USO DE TRATAMIENTO DEL VHC |
摘要 |
<p>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.</p> |
申请公布号 |
ES2529143(B1) |
申请公布日期 |
2015.10.26 |
申请号 |
ES20140090004 |
申请日期 |
2012.10.19 |
申请人 |
ABBVIE INC. |
发明人 |
BERNSTEIN, BARRY, M.;MENON, RAJEEV, M;KHATRI, AMIT;MENSING, SVEN;DUTTA, SANDEEP;COHEN, DANIEL E.;PODSADECKI, THOMAS J.;BRUN, SCOTT C;AWNI, WALID M.;DUMAS, EMILY O.;KLEIN, CHERI E. |
分类号 |
A61K31/7056;A61K31/4184;A61K31/7072;A61P31/12 |
主分类号 |
A61K31/7056 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|